Ioana Cristina Daha

Dr. Ioana Cristina Daha

1. Internal Medicine and Cardiology Department, Carol Davila, University of Medicine and Pharmacy, Bucharest, Romania
+1

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AVAncuta Vijan
Ancuta Vijan
IDIoana Cristina Daha
Ioana Cristina Daha
CDCaterina Delcea
Caterina Delcea
GDGheorghe-Andrei Dan
Gheorghe-Andrei Dan
Background and Aim: The increasing prevalence and high hospitalization rates make atrial fibrillation (AF) a significant healthcare strain. However, there are limited data regarding the length of hospital stay (LOS) of AF patients. Our purpose was to determine the main drivers of extended LOS of AF patients. Methods: All AF patients, hospitalized consecutively in a tertiary cardiology center, from January 2018 to February 2020 were included in this retrospective cohort study. Readmissions were excluded. Prolonged LOS was defined as more than seven days (the upper limit of the third quartile). Results: Our study included 949 AF patients, 52.9% females. The mean age was 72.5 ± 10.3 years. The median LOS was 4 days. A total of 28.7% had an extended LOS. Further, 82.9% patients had heart failure (HF). In multivariable analysis, the independent predictors of extended LOS were: acute coronary syndromes (ACS) (HR 4.60, 95% CI 1.66–12.69), infections (HR 2.61, 95% CI 1.44–3.23), NT-proBNP > 1986 ng/mL (HR 1.96, 95% CI 1.37–2.82), acute decompensated HF (ADHF) (HR 1.76, 95% CI 1.23–2.51), HF with reduced ejection fraction (HFrEF) (HR 1.69, 95% CI 1.15–2.47) and the HAS-BLED score (HR 1.42, 95% CI 1.14–1.78). Conclusion: ACS, ADHF, HFrEF, increased NT-proBNP levels, infections and elevated HAS-BLED were independent predictors of extended LOS, while specific clinical or therapeutical AF characteristics were not.

12 August 2019 in Journal of Evaluation in Clinical Practice
Verified
Journal Article
Closed access
PDF file
Cristian BaicusCristian Baicus
Cristian Baicus
PBPaul Balanescu
Paul Balanescu
SZStefan Zeh
Stefan Zeh
EOEmilia Oprisan
Emilia Oprisan
RLRozalina Lapadatu
Rozalina Lapadatu
CBCamelia Georgeta Badea
Camelia Georgeta Badea

3 November 2024 in Life
Verified
Journal Article
Open access
PDF file
AWArief Budi Witarto
Arief Budi Witarto
BCBogdan Ceachi
Bogdan Ceachi
CPCristiana Popp
Cristiana Popp
Sabina ZuracSabina Zurac
Sabina Zurac
IDIoana Cristina Daha
Ioana Cristina Daha
PMPetronel Mustatea
Petronel Mustatea
Tuberculosis is the primary cause of death due to infection in the world. Identification of Mycobacterium tuberculosis in sputum is a diagnostic test, which can be used in screening programs—especially in countries with a high incidence of tuberculosis—to identify and treat those persons with the highest risk of disseminating the infection. We previously developed an algorithm which is able to automatically detect mycobacteria on tissue; in particular, our algorithm identified acid-fast bacilli on tissue with 100% specificity, 95.65% sensitivity, and 98.33% accuracy. We tested this algorithm on 1059 Ziehl–Neelsen-stained sputum smears to evaluate its results as a possible tool for screening. The results were displayed as a heat map of 32 × 32 pixel patches. Analysis of the positive patches revealed a good specificity (86.84%) and 100% sensitivity for patches with a level of confidence over 90; furthermore, the accuracy remained over 95% for all levels of confidence over 80, except the class (95–100]. The modest specificity is caused by the peculiarities of smears (uneven thickness, dust contamination, lack of coverslip). We will train the algorithm on sputum smears to increase the specificity to over 95%. However, as our algorithm showed no false negatives, it is suitable for screening.

1 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AVAncuta Vijan
Ancuta Vijan
IDIoana Cristina Daha
Ioana Cristina Daha
CDCaterina Delcea
Caterina Delcea
EBElisabeta Badila
Elisabeta Badila
GDGheorghe-Andrei Dan
Gheorghe-Andrei Dan
Background and Aim: Atrial fibrillation (AF) is an epidemic disease with a significant global health impact. Atrial functional tricuspid regurgitation (AF-TR) is a more recently acknowledged complication of AF. The main purpose of this study was to determine the prognostic value of severe AF-TR in patients with AF, and its determinants. Methods: In this retrospective, observational study, we included AF patients admitted consecutively to a tertiary clinical hospital between January 2018 and February 2020, irrespective of cause of hospitalization. Patients with organic TR, significant pulmonary hypertension, left ventricular ejection fraction < 50%, those with implanted cardiac devices and those with in-hospital mortality were excluded. Severe TR was defined according to current guidelines. Median follow-up time was 34 (28–39) months. Primary endpoint was all-cause mortality. Results: We included 246 AF patients, with a mean age of 71.5 ± 9.4 years. 86.2% had AF-TR, while 8.1% had severe AF-TR. Mortality rate was 8.5%. Right atrial diameter (p = 0.005), systolic pulmonary artery pressure (sPAP) (p = 0.015) and NT-proBNP (p = 0.026) were independent predictors for the presence of severe valvular dysfunction. In multivariable survival analysis, severe AF-TR, was an independent predictor of all-cause mortality (HR 5.4, 95% CI 1.1–26.2, p = 0.035). Conclusion: Severe AF-TR was an independent predictor of mortality in AF patients, while mild/moderate AF-TR apparently had no impact on prognosis.

20 August 2024
Verified
Book Chapter
Open access
PDF file
IDIoana Cristina Daha
Ioana Cristina Daha
EBElisabeta Badila
Elisabeta Badila
Atrial fibrillation (AF) has an increasing prevalence and is foreseen as a true epidemic in the coming years. Moreover, the presence of AF has a huge impact on the everyday quality of life and also on the prognosis of the affected patients. Lifestyle interventions including exercise-based interventions are an essential component of the guideline-driven Atrial Fibrillation Better Care (ABC) pathway. Nevertheless, physicians are not extensively using this extremely valuable tool in AF prevention, both primary and secondary prevention, because of a lack of knowledge and fear of inducing harm. On the other hand, patients are afraid of experiencing symptoms and lower their physical activity to a “safe” minimum. Therefore, shedding light on this important topic is extremely important. The aim of the chapter is to highlight the bivalent and somehow counterintuitive relationship between exercise and atrial fibrillation with a special focus on exercise prescription in everyday AF patients.